Astrazeneca (AZN) Prepaid Assets (2009 - 2026)

Astrazeneca has reported Prepaid Assets for 18 years, with the latest figure at $75.0 million in Q2 2026.

• On a quarterly basis, Prepaid Assets rose 50.0% year-over-year to $75.0 million in Q2 2026; TTM through Jun 2026 was $75.0 million, a 50.0% increase from a year earlier, with the FY2025 full-year figure at $30.0 million, down 81.93% from the prior year.
• Prepaid Assets was $75.0 million for Q2 2026 at Astrazeneca, down from $115.0 million in the prior quarter.
• The five-year high for Prepaid Assets was $440.0 million in Q3 2022, with the low at $30.0 million in Q4 2025.
• Average Prepaid Assets over 5 years is $148.2 million, with a median of $140.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Prepaid Assets surged 436.59% in 2022, then sank 81.93% in 2025.
• Over 5 years, Prepaid Assets stood at $239.0 million in 2022, then tumbled by 48.95% to $122.0 million in 2023, then surged by 36.07% to $166.0 million in 2024, then tumbled by 81.93% to $30.0 million in 2025, then surged by 150.0% to $75.0 million in 2026.
• The last three Prepaid Assets figures came in at $75.0 million (Q2 2026), $115.0 million (Q1 2026), and $30.0 million (Q4 2025), per Business Quant data.